In the shadow of the statin festival
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, C.J. | - |
dc.date.available | 2019-06-10T08:30:29Z | - |
dc.date.issued | 2006-02 | - |
dc.identifier.issn | 1738-5520 | - |
dc.identifier.issn | 1738-5555 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/25555 | - |
dc.description.abstract | The efficacy of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) for reducing cardiovascular events has been established in large-scaled randomized controlled trials (RCT), and these trials have encompassed both primary and secondary prevention. Also, the safety of statins has been confirmed. Therefore, the market for statins is growing quite rapidly. Despite their proven benefits, a large number of patients who meet the guideline criteria for statin therapy are not receiving these drugs. Various strategies have been used to increase statin therapy in the target populations. However, the number of eligible patients taking statins has remained disappointing. It has been suggested that over-the-counter availability of statins would allow more consumers to use statins and achieve cardiovascular risk reduction. In contrast, those clinical trials have applied selection criteria to protect the internal validity at the expense of reducing the applicability of the trial's findings to the wider population of patients seen in routine clinical practice. Consequently, patients who are prescribed statins in routine clinical practice may systematically differ from those people who received statins in the clinical trials and may have different outcomes from those reported in the trials. This paper will review the efficacy of statins for preventing cardiovascular diseases, and suggest the pitfalls of the randomized controlled trails and the problems in the prescription of statins in the real clinical practice. © 2006, The Korean Society of Circulation. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Korean Society of Circulation | - |
dc.title | In the shadow of the statin festival | - |
dc.type | Article | - |
dc.identifier.doi | 10.4070/kcj.2006.36.2.77 | - |
dc.identifier.bibliographicCitation | Korean Circulation Journal, v.36, no.2, pp 77 - 83 | - |
dc.identifier.kciid | ART001137278 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-33646472334 | - |
dc.citation.endPage | 83 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 77 | - |
dc.citation.title | Korean Circulation Journal | - |
dc.citation.volume | 36 | - |
dc.type.docType | Review | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Hydroxymethylglutaryl-CoA reductase inhibitors | - |
dc.subject.keywordAuthor | Primary prevention | - |
dc.subject.keywordAuthor | Randomized controlled trial | - |
dc.subject.keywordAuthor | Secondary prevention | - |
dc.subject.keywordPlus | atorvastatin | - |
dc.subject.keywordPlus | cerivastatin | - |
dc.subject.keywordPlus | clofibrate | - |
dc.subject.keywordPlus | gemfibrozil | - |
dc.subject.keywordPlus | hydroxymethylglutaryl coenzyme A reductase inhibitor | - |
dc.subject.keywordPlus | low density lipoprotein cholesterol | - |
dc.subject.keywordPlus | nicotinic acid | - |
dc.subject.keywordPlus | pravastatin | - |
dc.subject.keywordPlus | cardiovascular disease | - |
dc.subject.keywordPlus | cardiovascular risk | - |
dc.subject.keywordPlus | clinical practice | - |
dc.subject.keywordPlus | diabetes mellitus | - |
dc.subject.keywordPlus | drug safety | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | hypertension | - |
dc.subject.keywordPlus | liver toxicity | - |
dc.subject.keywordPlus | review | - |
dc.subject.keywordPlus | rhabdomyolysis | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.